ArticleOncotarget2017
Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCC.
Leona L Pott et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this papercites it